Selective COX-2 Inhibitors and Dual Acting Anti-inflammatory Drugs: Critical Remarks
Open accessThe DOI matches its Crossref record.
Abstract
Non steroidal anti-inflammatory drugs (NSAIDs) are still the most commonly used remedies for rheumatic diseases. But NSAIDs produce serious adverse effects, the most important being gastric injury up to gastric ulceration and renal damage. Several strategies have been adopted in order to avoid these shortcomings, especially gastrointestinal toxicity. So, non steroidal anti-inflammatory drugs have been associated with gastroprotective agents that counteract the damaging effects of prostaglandin synthesis suppression: however, a combination therapy introduces problems of pharmacokinetics, toxicity, and patient s compliance. Also incorporation of a nitric oxide (NO)-generating moiety into the molecule of several NSAIDs was shown to greatly attenuate their ulcerogenic activity: however, several findings suggest a possible involvement of NO in the pathogenesis of arthritis and subsequent tissue destruction. A most promising approach seemed to be the preparation of novel NSAIDs, specific for the inducible isoform of cyclooxygenase (COX-2): they appear to be devoid of gastrointestinal toxicity, in that they spare mucosal prostaglandin synthesis. However, a number of recent studies raised serious questions about the two central tenets that support this approach, namely that the prostaglandins that mediate inflammation and pain are produced solely via COX-2 and that the prostaglandins that are important in gastrointestinal and renal function are produced solely via COX-1. So, increasing evidence shows that COX-2 (not only COX-1) also plays a physiological role in several body functions and that, conversely, COX-1 (not only COX-2) may also be induced at sites of inflammation. Moreover, COX-2 selective NSAIDs have lost the cardiovascular protective effects of non-selective NSAIDs, effects which are mediated through COX-1 inhibition (in addition, COX-2 has a role in sustaining vascular prostacyclin production). The products generated by the 5-lipoxygenase pathway (leukotrienes) are particularly important in inflammation: indeed, leukotrienes increase microvascular permeability and are potent chemotactic agents; moreover, inhibition of 5-lipoxygenase indirectly reduces the expression of TNF-alpha (a cytokine that plays a key role in inflammation). This explains the efforts to obtain drugs able to inhibit both 5-lipoxygenase and cyclooxygenases: the so-called dual acting anti-inflammatory drugs. Such compounds retain the activity of classical NSAIDs, while avoiding their main drawbacks, in that curtailed production of gastroprotective prostaglandins is associated with a concurrent curtailed production of the gastro-damaging and bronchoconstrictive leukotrienes. Moreover, thanks to their mechanism of action, dual acting anti-inflammatory drugs could not merely alleviate symptoms of rheumatic diseases, but might also satisfy, at least in part, the criteria of curative drugs. Indeed, leukotrienes are pro-inflammatory, increase microvascular permeability, are potent chemotactic agents and attract eosinophils, neutrophils and monocytes into the synovium. Finally, recent data strongly suggest that dual inhibitors may have specific protective activity also in neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Still being checked.
Cited by
Items 101–183 of 183
Kiani‐Esfahani, A., Kazemi, S., Peymani, M., Hashemi, M., Ghaedi, K., & Nasr‐Esfahani, M. H. (2016) · PubMed Central · doi:10.22074/cellj.2016.4314 · Cited by 18
Farooqi, S. I., Arshad, N., Channar, P. A., Perveen, F., Saeed, A., Larik, F. A., Javed, A., & Yamin, M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1766569 · Cited by 18
Transduced PEP-1-FK506BP inhibits the inflammatory response in the Raw 264.7 cell and mouse models
Kim, S. Y., Jeong, H. J., Kim, D. W., Kim, M. J., An, J. J., Sohn, E. J., Kang, H. W., Shin, M. J., Ahn, E. H., Kwon, S. W., et al. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.12.008 · Cited by 17
Antinociceptive activities of some triazole and pyrazoline moieties-bearing compounds
Özkay, Ü. D., Can, Ö. D., & Kaplancıklı, Z. A. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9619-z · Cited by 17
Ibrahim, T. S., Rashad, A. A., Abdel‐Samii, Z. K., El‐Feky, S. A., Abdel‐Hamid, M. K., & Barakat, W. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-9975-3 · Cited by 17
Lee, S. H., Kim, D. W., Back, S. S., Hwang, H. S., Park, E. Y., Kang, T., Kwon, O., Park, J. H., Cho, S., Han, K. H., et al. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.7.484 · Cited by 16
Postoperative Ketorolac in Breast and Body Contouring Procedures: A Nationwide Claims Analysis
Kelley, B., Chung, K. C., Chung, T., Bennett, K. G., Sacks, G. N., Sears, E. D., & Waljee, J. F. (2018) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000004806 · Cited by 16
Lino, R. C., da Silva, D. P. B., Florentino, I. F., da Silva, D. M., Martins, J. L. R., Batista, D. D. C., Leite, K. C. D. S., Villavicencio, B., Vasconcelos, G. A., Silva, A. L. P., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.06.006 · Cited by 16
Heterocyclic inflammation inhibitors
Sondhi, S. M., Rajvanshi, S., Singh, N., Jain, S., & Lahoti, A. M. (2004) · Open Chemistry · doi:10.2478/bf02476188 · Cited by 15
Neuroprotective Agents in the Intensive Care Unit
Panahi, Y., Mojtahedzadeh, M., Najafi, A., Rajaee, S. M., Torkaman, M., & Sahebkar, A. (2018) · Journal of pharmacopuncture · doi:10.3831/kpi.2018.21.026 · Cited by 14
Atia, H. A., Shahien, M. M., Ibrahim, S., Ahmed, E. H., Elariny, H. A., & Abdallah, M. H. (2024) · Gels · doi:10.3390/gels10080525 · Cited by 13
Leukotriene inhibition in small animal medicine
Goodman, L. A., COLES, T. B., & Budsberg, S. C. (2008) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2008.00963.x · Cited by 13
Fadda, A. A., & Elattar, K. M. (2015) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2015.311015 · Cited by 13
Hung, H.-C., Feng, C., Lin, Y., Chen, C., Tsui, K., Chen, W.-F., Pan, C., Sheu, J., Sung, C., & Wen, Z. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.272 · Cited by 13
Silvero-Isidre, A., Morínigo-Guayuán, S., Meza-Ojeda, A., Mongelós-Cardozo, M., Centurión-Wenninger, C., Figueredo-Thiel, S., Sanchez, D. F., & Acosta, N. (2017) · Parasitology Research · doi:10.1007/s00436-017-5693-6 · Cited by 11
Phytochemical studies and bioactivity of Centipeda and Eremophila species
Beattie, K. D. (2009) · Cross Connect (Southern Cross University) · Cited by 11
Ayaz, M., Alam, A., Zainab, Z., Fareed, G., Amin, A., Usman, M., Ali, L., Shah, S. A. A., Latif, A., Ali, M., et al. (2025) · ChemistrySelect · doi:10.1002/slct.202406068 · Cited by 9
Boufidou, F., & Halaris, A. E. (2017) · Modern trends in psychiatry · doi:10.1159/000470814 · Cited by 9
Advances in the therapy of hyperoxia-induced lung injury: findings from animal models.
Lv, R., Zheng, J., Ye, Z., Sun, X., Tao, H., Liu, K., Li, R., Xu, W., Liu, W., & Zhang, R. (2014) · PubMed · Cited by 9
Abdulaziz, F., Jamal, A., Faizi, M. S. H., Peedikakkal, A. M. P., Hussain, A., Al-Busaidi, I. J., Dege, N., Alenezi, K. M., & Haque, A. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.139796 · Cited by 8
Lee, M. J., Kim, D. W., Sohn, E. J., Jeong, H. J., Shin, M. J., Kang, H. W., Ahn, E. H., Kwon, S. W., Kim, Y. N., Won, M. H., et al. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.09.021 · Cited by 8
Shankar, B., Pochampally, J., Valeru, A., Sunitha, V., Balabadra, S., Manga, V., & Kudle, K. R. (2017) · Journal of Chemical Biology · doi:10.1007/s12154-017-0168-x · Cited by 8
Wang, Z., Tao, H., Chu, M., Yu, L., Wang, Q., Wang, Q., Lu, J., Wang, Z., Wang, Z., Zhang, H., et al. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad092 · Cited by 7
Prostaglandin E2 Enhances Gap Junctional Intercellular Communication in Clonal Epithelial Cells
del Toro, A. O., Jimenez, L., Rubi, M. S., Castillo, A., Hinojosa, L., Martínez‐Rendón, J., Cereijido, M., & Ponce, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115813 · Cited by 7
Bilal, A., Mehmood, A., Noureen, S., Claude Lecomte, B., & Ahmed, M. (2022) · CrystEngComm · doi:10.1039/d2ce01179d · Cited by 7
Huang, B., Cheng, J., Wu, C., Chen, P., Tu, P. S., Fu, Y., & Wu, C. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.07.014 · Cited by 6
Amid, A. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.2737 · Cited by 6
Salazar, F. J., Salazar, F. J., Sáez, F., Reverte, V., Zweifel, B. S., Dufield, D. R., Radabaugh, M. R., Graneto, M. J., Llinás, M. T., & Masferrer, J. L. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31828399ae · Cited by 4
Própolis verde brasileira: citotoxicidade e potencial anti-inflamatório in vitro
Pimentel, C. D. A., Fracasso, J. A. R., da Costa, L. T. S., Ferreira, F. Y. D., Guarnier, L. P., Brasil, G. S. P., Berretta, A. A., & dos Santos, L. (2022) · Brazilian Journal of Development · doi:10.34117/bjdv8n11-394 · Cited by 4
Ginex, T., Muñoz, J. A., Herrero, E., Gibert, E., Cozzini, P., & Luque, F. J. (2016) · Journal of Molecular Modeling · doi:10.1007/s00894-016-2991-3 · Cited by 4
Moharir, S., Khobragade, P. P., Rane, R. A., Suryawanshi, M. R., Pal, K., Gawade, B., Kumar, D., & Satpute, B. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.04.019 · Cited by 3
Gurav, A. P., Bhosale, L., Swami, P., Chavan, P. N., Ladkat, P. D., Patil, P. S., Nerlekar, N., Dandge, P. B., Rochlani, S. P., Sankpal, S., et al. (2025) · ChemistrySelect · doi:10.1002/slct.202501657 · Cited by 3
Synthesis and structural features of N-[(2-(trimethylsilyl)oxy)phenyl]-arylsulfonamides
Nikonov, А. Y., Sterkhova, I. V., Serykh, V. Y., Kolyvanov, N. A., & Lazareva, N. F. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.07.029 · Cited by 3
Alagumuthu, M., Srivastava, V., Shah, M., Arumugam, S., Mohandoss, S., & Napoleon, A. A. (2019) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523019666191226104724 · Cited by 3
Salazar, F. J., & Llinás, M. T. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00489.2010 · Cited by 3
Kim, K., Kim, S. H., & Jang, H.-J. (2011) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-011-0010-x · Cited by 2
Safety Assessment of an Oral Therapeutic Dose of Firocoxib on Healthy Horses
de Araújo, R. A., de Sales, N. A. A., Basile, R. C., Junior, W. H. F., Apparício, M., Ferraz, G. D. C., & Queiroz-Neto, A. (2023) · Veterinary Sciences · doi:10.3390/vetsci10090531 · Cited by 2
Ahn, E.-H., Kim, D. W., Kim, D.-S., Woo, S.-J., Kim, H. R., Kim, J., Lim, S. S., Kang, T., Kim, D. J., Suk, K. T., et al. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.5.329 · Cited by 2
Puangpraphant, S. (2012) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 2
Cooper, D. L. (2016) · Digital Commons - East Tennessee State University (East Tennessee State University) · Cited by 2
Licofelone in osteoarthritis: is this the awaited drug? a systematic review
Vinod Kumar, P. (2021) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20211654 · Cited by 2
Síntesis de nuevos compuestos con potencial actividad antitumoral y/o antiinflamatoria
Rivera, L. N. (2018) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 2
Non-steroidal anti-inflammatory drugs for treating acute ankle sprains in adults
van den Bekerom, M. P. J., Sjer, A., Struijs, P. A. A., Blankevoort, L., van Dijk, C. N., & Kerkhoffs, G. M. M. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008810 · Cited by 2
Alfadil, A., Ibrahem, K. A., Al-Rabia, M. W., Ali, A. S., Barakat, J., & Bakheit, K. H. (2024) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.1387 · Cited by 1
Spinal Stargazin-Mediated Cross-Talk of AMPA/NMDA Receptors in Chronic Pain
Wu, H., & Tao, F. (2012) · Analgesia & Resuscitation Current Research · doi:10.4172/2324-903x.1000101 · Cited by 1
COMBINATION TREATMENTS USING VANCOMYCIN WITH IMMUNOMODULATORS TO MODULATE STAPHYLOCOCCAL ARTHRITIS
Dutta, S., & Bishayi, B. (2016) · Asian Journal of Pharmaceutical and Clinical Research · Cited by 1
Nikonov, А. Y., Sterkhova, I. V., & Lazareva, N. F. (2021) · Russian Chemical Bulletin · doi:10.1007/s11172-021-3097-3 · Cited by 1
Serratiopeptidase: The Healing Enzyme
Rakshe, M. P. S., Kumbhar, M. J., & Tambe, M. A. V. (2022) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-4070 · Cited by 1
Rabiu, Z., Hasham, R., & Zakaria, Z. A. (2019) · Jurnal Kejuruteraan · doi:10.17576/jkukm-2019-si2(1)-07 · Cited by 1
Potential effects of triterpenoids in osteoarthritis model systems
Shah, N. (2012) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t32j69sj · Cited by 1
Non-steroidal anti-inflammatory drugs for treating acute ankle sprains in adults
van den Bekerom, M. P. J., Sjer, A., Struijs, P. A. A., Blankevoort, L., van Dijk, C. N., & Kerkhoffs, G. M. M. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008810.pub2 · Cited by 1
Kolgazi, M. (2013) · Marmara University Open Access System · Cited by 1
Hanke, T. (2014) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · Cited by 1
Eicosanoid Regulation of Hematopoietic Stem and Progenitor Cell Function
Hoggatt, J. (2010) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1697
THE ROLE OF SMAC IN NSAID-INDUCED APOPTOSIS
Bank, A. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
DESIGN OF COX-2 INHIBITORS-AN IN-SILICO APPROACH Original Article
Giles, D., Prabha, S., & Pm, G. B. (2015)
Sklyarova, Y. O., Denysenko, N. V., Ilkiv, I., & Fomenko, I. (2016) · Medical and Clinical Chemistry · doi:10.11603/mcch.2410-681x.2016.v0.i3.6945
Doyle, H. H. (2017) · Digital Archive @ GSU · doi:10.57709/10165308
Evaluation of the antioxidant and anti-inflammatory activities of synthetic 2-styrylchromones
Gomes, A. M. D. C. M. (2011)
Anti-inflammatorische Wirkung von 7,8-Dihydroxyflavon auf Mikroglia
Stöckel, R. (2017) · MACAU: Open Access Repository of Kiel University
Fomenko, I., Sklyarov, P., & Lesyk, R. (2017) · Experimental and Clinical Physiology and Biochemistry · doi:10.25040/ecpb2017.02.024
Kamphuijs, S. J. (2016) · Utrecht University Repository (Utrecht University)
Effect of grape components on periodontal disease.
Shivde, J. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3094
Moro, M. G. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.23.2019.tde-07082019-144534
Kim, J.-I., Choi, Y.-W., Choi, G.-J., Kang, J.-A., Lee, I.-Y., Narantuya, N., Oh, M.-S., Cho, S.-J., & Moon, J.-Y. (2021) · JoLS Journal of Life Sciences · doi:10.5352/jls.2021.31.1.17
Suh, D. H., & Song, Y. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101577
Suh, D. H., & Song, Y. S. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101577-1
Merabet‐Khelassi, M., Kilani‐Morakchi, S., Sifi, K., & Zeror, S. (2025) · Biocatalysis and Biotransformation · doi:10.1080/10242422.2025.2495009
Gurzhenko, Y., Shulyak, O., Spyrydonenko, V., & Gurzhenko, O. (2025) · Ukrainian Journal of Urology · doi:10.71217/uju.2(6).2025.53-69
Inhibition der Cyclooxygenase bei destruktiven Gelenkerkrankungen
Haussleiter, I. S. (2005) · Dokumentenrepositorium der RUB (Ruhr University Bochum)
Evaluation of the antioxidant and anti-inflammatory activities of synthetic 2-styrylchromones
Gomes, A. M. D. C. M. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/8jmq-tg64
Cruz-Ruiz, E. S., Trujillo-Ferrara, J. G., Morán-Díaz, J. R., & Guevara‐Salazar, J. A. (2026) · Preprints.org · doi:10.20944/preprints202602.0258.v1
Duong, T. T. M. (2016) · theses.fr (ABES) · doi:10.70675/a3fc9563zfabez48ffzb3f3zd2544d626f9b
BindingDB (2024) · UC San Diego · doi:10.7270/q28w3jhj
BindingDB Entry 50002777: Synthesis and biological properties of aryl methyl sulfones.
BindingDB (2020) · UC San Diego · doi:10.7270/q2s1855f
ESTUDO DA SEGURANÇA DA DOSE TERAPÊUTICA ORAL DO FIROCOXIB EM EQUINOS
de Araújo, R. A. (2012) · Americanae (AECID Library)
Metadata
- Authors
- Bertolini, A., Ottani, A., & Sandrini, M.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Sandrini, M.
- ORCID
- Ottani, A.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2002-05-01
- Volume
- 9
- Issue
- 10
- Pages
- 1033-1043
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2123833658
- Cited by
- 158
- References
- 0
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 4 · 2018: 11 · 2017: 13 · 2016: 11 · 2015: 11 · 2014: 8 · 2013: 5 · 2012: 12
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by
- Locations
- Current Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- COX-2 inhibitors, nonsteroidal anti-inflammatory drugs, cyclooxygenase-1, cyclooxygenase-2, 5-lipoxygenase inhibition, leukotrienes, prostaglandins, gastrointestinal toxicity, nephrotoxicity, cardioprotection, prostacyclin, TNF-α, rheumatic diseases, adverse drug reactions, nitric oxide, gastroprotective agents
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Capillary Permeability, Gastrointestinal Diseases, Humans, Isoenzymes, Lipoxygenase, Membrane Proteins, Pain, Prostaglandin-Endoperoxide Synthases, Rheumatic Diseases, Synovial Membrane, Leukotrienes, Cyclooxygenase Inhibitors, Neurodegenerative Diseases, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.